Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (Deficit)

v3.21.2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Preferred Stock
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital Amount
Accumulated Other Comprehensive Income (Loss) Amount
Accumulated Deficit Amount
Beginning Balance (in shares) at Jan. 31, 2020   282,108              
Beginning Balance at Jan. 31, 2020   $ 996,389              
Ending Balance (in shares) at Apr. 30, 2020   282,108              
Ending Balance at Apr. 30, 2020   $ 996,389              
Beginning Balance (in shares) at Jan. 31, 2020         41,883 115,741      
Beginning Balance at Jan. 31, 2020 $ (799,511)       $ 0 $ 1 $ 72,229 $ 6,226 $ (877,967)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)         2,166        
Issuance of common stock upon exercise of stock options 536           536    
Compensation expense related to secondary transactions 35           35    
Stock-based compensation expense 8,166           8,166    
Other comprehensive income (loss), net 8,313             8,313  
Net loss (52,840)               (52,840)
Ending Balance (in shares) at Apr. 30, 2020         44,049 115,741      
Ending Balance at Apr. 30, 2020 (835,301)       $ 0 $ 1 80,966 14,539 (930,807)
Beginning Balance (in shares) at Jan. 31, 2020   282,108              
Beginning Balance at Jan. 31, 2020   $ 996,389              
Ending Balance (in shares) at Oct. 31, 2020   294,257              
Ending Balance at Oct. 31, 2020   $ 1,221,968              
Beginning Balance (in shares) at Jan. 31, 2020         41,883 115,741      
Beginning Balance at Jan. 31, 2020 (799,511)       $ 0 $ 1 72,229 6,226 (877,967)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income (loss), net (10,083)                
Net loss (118,649)   $ (35,144) $ (83,505)          
Ending Balance (in shares) at Oct. 31, 2020         63,374 113,116      
Ending Balance at Oct. 31, 2020 (848,837)       $ 1 $ 1 151,634 (3,857) (996,616)
Beginning Balance (in shares) at Apr. 30, 2020   282,108              
Beginning Balance at Apr. 30, 2020   $ 996,389              
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of convertible preferred stock, net of issuance costs (in shares)   12,149              
Issuance of convertible preferred stock, net of issuance costs   $ 225,579              
Ending Balance (in shares) at Jul. 31, 2020   294,257              
Ending Balance at Jul. 31, 2020   $ 1,221,968              
Beginning Balance (in shares) at Apr. 30, 2020         44,049 115,741      
Beginning Balance at Apr. 30, 2020 (835,301)       $ 0 $ 1 80,966 14,539 (930,807)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)         7,600        
Issuance of common stock upon exercise of stock options 2,184       $ 1   2,183    
Stock-based compensation expense 8,829           8,829    
Other comprehensive income (loss), net (23,942)             (23,942)  
Net loss 4,987               4,987
Ending Balance (in shares) at Jul. 31, 2020         51,649 115,741      
Ending Balance at Jul. 31, 2020 (843,243)       $ 1 $ 1 91,978 (9,403) (925,820)
Ending Balance (in shares) at Oct. 31, 2020   294,257              
Ending Balance at Oct. 31, 2020   $ 1,221,968              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)         9,097        
Issuance of common stock upon exercise of stock options 9,348           9,348    
Vesting of early exercised stock options 1,544           1,544    
Issuance of common stock upon settlement of restricted stock units/vesting of restricted stock awards (in shares)         3        
Issuance of common stock upon vesting of restricted stock awards 121           121    
Compensation expense related to secondary transactions (in shares)         2,625 (2,625)      
Stock-based compensation expense 48,643           48,643    
Other comprehensive income (loss), net 5,546             5,546  
Net loss (70,796)   (22,969) (47,827)         (70,796)
Ending Balance (in shares) at Oct. 31, 2020         63,374 113,116      
Ending Balance at Oct. 31, 2020 $ (848,837)       $ 1 $ 1 151,634 (3,857) (996,616)
Beginning Balance (in shares) at Jan. 31, 2021 294,257 294,257              
Beginning Balance at Jan. 31, 2021 $ 1,221,968 $ 1,221,968              
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of convertible preferred stock, net of issuance costs (in shares)   12,043              
Issuance of convertible preferred stock, net of issuance costs   $ 749,836              
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)   (306,300)     306,300        
Conversion of convertible preferred stock to common stock upon initial public offering 1,971,804 $ (1,971,804)     $ 3   1,971,801    
Ending Balance (in shares) at Apr. 30, 2021   0              
Ending Balance at Apr. 30, 2021   $ 0              
Beginning Balance (in shares) at Jan. 31, 2021         75,177 110,653      
Beginning Balance at Jan. 31, 2021 (803,704)       $ 1 $ 1 179,175 (12,521) (970,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)   (306,300)     306,300        
Conversion of convertible preferred stock to common stock upon initial public offering 1,971,804 $ (1,971,804)     $ 3   1,971,801    
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs (in shares)         13,000        
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs 687,903           687,903    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)         28,200        
Conversion of shares of Class B common stock into shares of Class A common stock           $ (28,200)      
Shares issued as consideration for business acquisition (in shares)         543        
Shares issued as consideration for business acquisition 30,446           30,446    
Issuance of common stock upon exercise of stock options (in shares)         1,881        
Issuance of common stock upon exercise of stock options 3,114           3,114    
Vesting of early exercised stock options 1,646           1,646    
Issuance of common stock upon settlement of restricted stock units/vesting of restricted stock awards (in shares)         389        
Tax withholdings on settlement of restricted stock units (in shares)         (164)        
Tax withholdings on settlement of restricted stock units (9,218)           (9,218)    
Stock-based compensation expense 252,986           252,986    
Other comprehensive income (loss), net 4,227             4,227  
Net loss (239,663)               (239,663)
Ending Balance (in shares) at Apr. 30, 2021         425,326 82,453      
Ending Balance at Apr. 30, 2021 $ 1,899,541       $ 4 $ 1 3,117,853 (8,294) (1,210,023)
Beginning Balance (in shares) at Jan. 31, 2021 294,257 294,257              
Beginning Balance at Jan. 31, 2021 $ 1,221,968 $ 1,221,968              
Ending Balance (in shares) at Oct. 31, 2021 0 0              
Ending Balance at Oct. 31, 2021 $ 0 $ 0              
Beginning Balance (in shares) at Jan. 31, 2021         75,177 110,653      
Beginning Balance at Jan. 31, 2021 $ (803,704)       $ 1 $ 1 179,175 (12,521) (970,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 7,723                
Other comprehensive income (loss), net $ 16,352                
Net loss (462,476)   (364,403) (98,073)          
Ending Balance (in shares) at Oct. 31, 2021         442,357 82,453      
Ending Balance at Oct. 31, 2021 1,883,405       $ 4 $ 1 3,312,405 3,831 (1,432,836)
Beginning Balance (in shares) at Apr. 30, 2021   0              
Beginning Balance at Apr. 30, 2021   $ 0              
Ending Balance (in shares) at Jul. 31, 2021   0              
Ending Balance at Jul. 31, 2021   $ 0              
Beginning Balance (in shares) at Apr. 30, 2021         425,326 82,453      
Beginning Balance at Apr. 30, 2021 1,899,541       $ 4 $ 1 3,117,853 (8,294) (1,210,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued as consideration for business acquisition 21           21    
Issuance of common stock upon exercise of stock options (in shares)         2,993        
Issuance of common stock upon exercise of stock options 3,537           3,537    
Vesting of early exercised stock options 615           615    
Issuance of common stock upon settlement of restricted stock units/vesting of restricted stock awards (in shares)         2,492        
Tax withholdings on settlement of restricted stock units (in shares)         (18)        
Tax withholdings on settlement of restricted stock units (1,175)           (1,175)    
Stock-based compensation expense 92,744           92,744    
Other comprehensive income (loss), net 3,696             3,696  
Net loss (100,026)               (100,026)
Ending Balance (in shares) at Jul. 31, 2021         430,793 82,453      
Ending Balance at Jul. 31, 2021 $ 1,898,953       $ 4 $ 1 3,213,595 (4,598) (1,310,049)
Ending Balance (in shares) at Oct. 31, 2021 0 0              
Ending Balance at Oct. 31, 2021 $ 0 $ 0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares)         2,848        
Issuance of common stock upon exercise of stock options 3,209           3,209    
Vesting of early exercised stock options 462           462    
Issuance of common stock upon settlement of restricted stock units/vesting of restricted stock awards (in shares)         8,720        
Tax withholdings on settlement of restricted stock units (in shares)         (4)        
Tax withholdings on settlement of restricted stock units (199)           (199)    
Stock-based compensation expense 95,338           95,338    
Other comprehensive income (loss), net 8,429             8,429  
Net loss (122,787)   $ (103,747) $ (19,040)         (122,787)
Ending Balance (in shares) at Oct. 31, 2021         442,357 82,453      
Ending Balance at Oct. 31, 2021 $ 1,883,405       $ 4 $ 1 $ 3,312,405 $ 3,831 $ (1,432,836)